BIOXODES
La probabilité de faillite calculée de BIOXODES sur 12 mois est de 0,3% (très faible). L'entreprise est active depuis 2010 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 16 ans |
| Direction | 13 |
| Sites | 1 |
| Publications | 77 |
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2024 | volledig | 16-07-2025 | 2025-00274086 |
| 31-12-2023 | volledig | 23-07-2024 | 2024-00271025 |
| 31-12-2022 | volledig | 14-07-2023 | 2023-00235430 |
| 31-12-2021 | volledig | 23-08-2022 | 2022-20305384 |
| 31-12-2020 | volledig | 13-07-2021 | 2021-34200330 |
| 31-12-2019 | volledig | 04-08-2020 | 2020-37700413 |
| 31-12-2018 | volledig | 25-06-2019 | 2019-21500537 |
| 31-12-2017 | volledig | 31-07-2018 | 2018-40100346 |
| 31-12-2016 | volledig | 08-08-2017 | 2017-41400415 |
| 31-12-2015 | volledig | 30-06-2016 | 2016-24900476 |
-
PHMBIO+Personne moraleAdministrateur· repr. perm.: Philippe MONTEYNEActe Moniteur 25131560 (16-10-2025)Actif02-10-2025 → auj.
-
Actif05-10-2022 → auj.
2 événements
- 08-11-2022 Nommé· Administrateur
- 05-10-2022 Mandat renouvelé· Gestion journalière
-
SAS CROUGHS R&D CONSULTINGPersonne moraleAdministrateur· repr. perm.: Thérèse CroughsActe Moniteur 21036646 (23-03-2021)Actif15-12-2020 → auj.
-
JCO ConsultingPersonne moraleAdministrateur· repr. perm.: Jean CombalbertActe Moniteur 19107912 (08-08-2019)Actif01-01-2019 → auj.
-
AJE ConsultingPersonne moraleAdministrateur· repr. perm.: GODFROID EdmondActe Moniteur 15132919 (18-09-2015)Actif18-09-2015 → auj.
-
Actif18-09-2015 → auj.
-
Life Sciences Research PartnersPersonne moraleAdministrateur· repr. perm.: BUYSE ChrisActe Moniteur 15132919 (18-09-2015)Actif18-09-2015 → auj.
-
Actif01-01-2014 → auj.
2 événements
- 18-09-2015 Mandat renouvelé· Administrateur
- 01-01-2014 Nommé· Administrateur
-
JCO ConsultingPersonne moraleAdministrateur· repr. perm.: COMBALBERT JeanActe Moniteur 15132919 (18-09-2015)Actif10-12-2013 → auj.
2 événements
- 18-09-2015 Mandat renouvelé· Administrateur
- 10-12-2013 Nommé· Administrateur
-
SPRL AJE CONSULTINGPersonne moraleAdministrateur· repr. perm.: Edmond GodfroidActe Moniteur 14105977 (23-05-2014)Actif10-12-2013 → auj.
2 événements
- 10-12-2013 Nommé· Administrateur
- 10-12-2013 Nommé· Administrateur délégué
-
CAPITAL & CROISSANCEPersonne moraleAdministrateur· repr. perm.: DETRIXHE PierreActe Moniteur 15132919 (18-09-2015)Actif10-07-2013 → auj.
2 événements
- 18-09-2015 Mandat renouvelé· Administrateur
- 10-07-2013 Nommé· Administrateur
-
Actif10-07-2013 → auj.
-
Actif10-07-2013 → auj.
Anciens dirigeants (8)
-
AJE CONSULTING SRLPersonne moraleGestion journalière· repr. perm.: Edmond GODFROIDActe Moniteur 22130605 (04-11-2022)Ancien05-10-2022 → 16-12-2024
3 événements
- 16-12-2024 Démission· Administrateur
- 16-12-2024 Démission· Administrateur délégué
- 05-10-2022 Mandat renouvelé· Gestion journalière
-
Ancien10-07-2013 → 01-01-2019
2 événements
- 01-01-2019 Démission· Administrateur
- 10-07-2013 Nommé· Administrateur
-
SPRL TCF ConsultingPersonne moraleAdministrateur· repr. perm.: Oliver BoucherActe Moniteur 15090815 (26-06-2015)Ancien— → 10-06-2015
-
SPRL TCF ConsuitingPersonne moraleGestion journalière· repr. perm.: Oliver BoucherActe Moniteur 15048473 (02-04-2015)Ancien— → 21-01-2015
-
SPRL CARKATHPersonne moraleAdministrateur· repr. perm.: Eric HaliouaActe Moniteur 14143093 (24-07-2014)Ancien— → 01-01-2014
-
Ancien04-07-2013 → 10-12-2013
7 événements
- 10-12-2013 Démission· Administrateur
- 10-12-2013 Démission· Administrateur délégué
- 10-07-2013 Nommé· Administrateur délégué
- 10-07-2013 Mandat renouvelé· Administrateur
- 04-07-2013 Nommé· Administrateur délégué
- 04-07-2013 Nommé· Administrateur
- 04-07-2013 Démission· Administrateur
-
Ancien04-07-2013 → 10-07-2013
2 événements
- 10-07-2013 Démission· Administrateur
- 04-07-2013 Nommé· Administrateur
-
Ancien04-07-2013 → 10-07-2013
2 événements
- 10-07-2013 Démission· Administrateur
- 04-07-2013 Nommé· Administrateur
| Commissaire / réviseur | Numéro IRE/IBR | Période |
|---|---|---|
| PwC Réviseurs d'Entreprises SRLActif Commissaire · représenté par Didier DELANOYE |
— | 27-02-2025 → auj. |
| NACE primaire | 72101 |
| Forme juridique | SA(014) |
| Date de constitution | 20-04-2010 |
| Status | Actif |
| Code postal | 6041 |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
16-10-2025 2 administrateurs nommés
- SRL PHMBIO+ — Bestuurder
- SRL PHMBIO+ — Président du conseil d'administration
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "SRL PHMBIO\u002B",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "pr\u00E9sident du conseil d\u0027administration",
"person": {
"rrn": null,
"name": "SRL PHMBIO\u002B",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}16-10-2025 4 administrateurs nommés
- Philippe MONTEYNE — Bestuurder
- Francine MESSINNE — Dagelijks bestuur
- Philippe MONTEYNE — Dagelijks bestuur
- Francine MESSINNE — Dagelijks bestuur
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-10-02",
"evidence_quote": "act\u00E9 la d\u00E9signation comme administrateur: la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": 1
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "approuv\u00E9 la r\u00E9mun\u00E9ration de l\u0027administrateur pour son mandat de pr\u00E8sident du conseil d\u0027administration",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "mandat\u00E9 Me Francine MESSINNE, aux fins de d\u00E9p\u00F4t et de publication de ces d\u00E9cisions",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "0631.922.633",
"name": "PHMBIO\u002B",
"address": "All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2025-10-02",
"evidence_quote": "d\u00E9sign\u00E8 la la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Le conseil a mandat\u00E9 Me Francine MESSINNE aux fins de d\u00E9p\u00F4t et de publication de ces d\u00E9cisions",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-10-16",
"filing_date": "2025-10-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-10-02",
"unanimous": null
},
{
"body": "raad_van_bestuur",
"date": "2025-10-02",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "mandataire sp\u00E9ciale"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}16-10-2025 Philippe MONTEYNE nommé administrateur
- Philippe MONTEYNE — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Philippe MONTEYNE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0631922633",
"name": "SRL PHMBIO\u002B",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2025-10-02",
"evidence_quote": "act\u00E9 la d\u00E9signation comme administrateur: la SRL PHMBIO\u002B, ayant pour repr\u00E9sentant permanent M. Philippe MONTEYNE, immatricul\u00E9e \u00E0 la BCE sous le n\u00BA BE0631.922.633 et ayant son si\u00E8ge All\u00E9e Bois de Bercuit 101, 1390 Grez-Doiceau, pour une dur\u00E9e d\u0027un an avec effet imm\u00E9diat et jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9ral"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}01-07-2025 Réduction de capital de 9.069.205,78 € à 395.844,41 €
- €9.465.050,19 → €395.844,41
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 8398992.55,
"currency": "EUR",
"after_eur": 9465050.19,
"delta_eur": 8398992.55,
"before_eur": 1066057.64,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 une augmentation de capital, sans cr\u00E9ation de titres, par incorporation des primes d\u2019\u00E9mission constitu\u00E9es lors de pr\u00E9c\u00E9dentes augmentations de capital, d\u0027un montant total de 8.398.992,55 \u20AC pour porter le capital temporairement de 1.066.057,64 \u20AC \u00E0 9.465. 050,19 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 9069205.78,
"currency": "EUR",
"after_eur": 395844.41,
"delta_eur": -9069205.78,
"before_eur": 9465050.19,
"amount_type": "kapitaal_effectief",
"effective_date": "2025-06-26",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 9.069.205,78 \u20AC, sans annulation de titres, pour le ramener de 9.465. 050,19 \u20AC \u00E0 395.844,41 \u20AC, par apurement \u00E0 due concurrence de la perte report\u00E9e figurant \u00E0 la situation comptable arr\u00EAt\u00E9e au 31 d\u00E9cembre 2024.",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}01-07-2025 Réduction de capital de 9.069.205,78 € à 395.844,41 €
- €9.465.050,19 → €395.844,41
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9465050.19,
"delta_eur": 8398992.55,
"before_eur": 1066057.64,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "reserves_incorporation",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_decrease",
"after_eur": 395844.41,
"delta_eur": -9069205.78,
"before_eur": 9465050.19,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "loss_absorption",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-07-01",
"filing_date": "2025-06-27",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2025-06-26",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}01-07-2025 Augmentation de capital de 8.398.992,55 € à 9.465.050,19 €
- €1.066.057,64 → €9.465.050,19
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9465050.19,
"delta_eur": 8398992.549999999,
"before_eur": 1066057.64,
"contribution_type": "reserves_incorporation"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}27-02-2025 1 administrateur nommé, 2 démissionnaires
- Didier DELANOYE — Commissaris
- Edmond GODFROID — Bestuurder
- Edmond GODFROID — Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-12-16",
"evidence_quote": "act\u00E9 la d\u00E9mission de AJE CONSULTING SRL, ayant pour repr\u00E9sentant permament M. Edmond GODFROID, de ses fonctions d\u0027administrateur et de d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re, avec effet au 16 d\u00E9cembre 2024"
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "d\u00E9sign\u00E9 la SRL PwC R\u00E9viseurs d\u0027Entreprises, en qualit\u00E9 de commissaire de la Soci\u00E9t\u00E9, pour une dur\u00E9e de quatre ans, jusqu\u0027\u00E0 l\u0027assembl\u00E9e g\u00E9n\u00E9rale charg\u00E9e d\u0027approuver les comptes annuels arr\u00EAt\u00E9s au 31 d\u00E9cembre 2017. Le repr\u00E9sentant permanent est M. Didier DELANOYE"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}27-02-2025 2 administrateurs nommés, 1 démissionnaire
- Didier DELANOYE — Commissaris
- Francine MESSINNE — Dagelijks bestuur
- Edmond GODFROID — Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur_d\u00E9l\u00E9gu\u00E9",
"person": {
"rrn": null,
"name": "Edmond GODFROID",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": "2024-12-16",
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Didier DELANOYE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "4"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Francine MESSINNE",
"address": null,
"birth_date": null,
"profession": "avocate",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2025-02-27",
"filing_date": "2025-02-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2025-02-06",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "mandataire sp\u00E9ciale"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}27-02-2025 1 administrateur nommé, 2 démissionnaires
- SRL PwC Réviseurs d'Entreprises — Commissaire
- AJE CONSULTING SRL — Bestuurder
- AJE CONSULTING SRL — Dagelijks bestuur
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "SRL PwC R\u00E9viseurs d\u0027Entreprises",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}02-07-2024 Augmentation de capital
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}02-07-2024 Opération sur le capital ou les actions
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}02-07-2024 Augmentation de capital
- 4 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": "ordinaire",
"n_new_shares": 493874,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3.484
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-07-02",
"filing_date": "2024-06-28",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2024-06-27",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP Petit \u0026 Co",
"ibr_number": null,
"mission_type": "fusion_special_report",
"individual_name": "Val\u00E9rie Denis"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"Rapport sp\u00E9cial du conseil d\u2019administration",
"Rapport du R\u00E9viseur d\u0027Entreprises",
"Plans de Warrants"
],
"shareholders_after": [],
"share_classes_after": []
}11-01-2024 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}11-01-2024 Augmentation de capital de 2.456,50 € à 1.066.057,64 €
- €1.063.601,14 → €1.066.057,64
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"share_emission": {
"agio_eur": 41760.5,
"share_form": "pair_comptable",
"share_class": "ordinaires",
"n_new_shares": 24565,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1.7
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 2456.5,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": "privil\u00E9gi\u00E9es",
"n_new_shares": 7361931,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": null,
"office_city": "Schaerbeek",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-01-11",
"filing_date": "2024-01-08",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-01-08",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": "2024-01-05"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 8001496,
"class_name": "ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 7361931,
"class_name": "privil\u00E9gi\u00E9es",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}11-01-2024 Augmentation de capital de 2.456,50 € à 1.066.057,64 €
- €1.063.601,14 → €1.066.057,64
- Inbreng in geld · Apport en numéraire
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}11-01-2024 Changement au sein de l'organe d'administration
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}11-01-2024 Augmentation de capital de 2.456,50 € à 1.066.057,64 €
- €1.063.601,14 → €1.066.057,64
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 2456.5,
"currency": "EUR",
"after_eur": 1066057.64,
"delta_eur": 2456.5,
"before_eur": 1063601.14,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-01-08",
"evidence_quote": "L\u0027administrateur pr\u00E9cit\u00E9 constate l\u0027augmentation de capital de 2.456,50 \u20AC pour le porter de 1.063.601,14 \u20AC \u00E0 1.066.057,64 \u20AC par la cr\u00E9ation de 24.565 actions ordinaires nouvelles... Les actions nouvelles ont \u00E9t\u00E9 souscrites en esp\u00E8ces",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}31-10-2023 Augmentation de capital de 372.938,70 € à 1.063.601,14 €
- €690.662,44 → €1.063.601,14
- 3 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "eenhoofdigheid_declaration",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"share_emission": {
"agio_eur": 3642265.67,
"share_form": "no_nominal_value",
"share_class": "privil\u00E9gi\u00E9es",
"n_new_shares": 1070307,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 3.484409
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Simon Wets",
"firm_city": null,
"firm_name": "Benjamin Wets \u0026 Simon Wets, notaires associ\u00E9s",
"office_city": "Schaerbeek",
"is_associated": true
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-10-31",
"filing_date": "2023-10-27",
"act_kind_objet": "Objet de l\u0027acte : CAPITAL, ACTIONS"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2023-10-26",
"unanimous": true,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "CDP Petit \u0026 Co",
"ibr_number": null,
"mission_type": "apport_nature",
"individual_name": "Val\u00E9rie Denis"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"rapport sp\u00E9cial du Conseil d\u2019administration",
"rapport dress\u00E9 par le Reviseur d\u0027Entreprises",
"plan financier",
"bankattest",
"verslag bedrijfsrevisor"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 615000,
"class_name": "ordinaires",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 7361931,
"class_name": "privil\u00E9gi\u00E9es",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}31-10-2023 Augmentation de capital de 372.938,70 € à 1.063.601,14 €
- €690.662,44 → €1.063.601,14
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 372938.7,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide d\u0027augmenter le capital \u00E0 concurrence de 372.938,70 \u20AC, pour le porter de 690.662,44 \u00E0 1.063.601,14 \u20AC",
"contribution_type": "in_kind"
},
{
"kind": "capital_increase",
"amount": 1200000,
"currency": "EUR",
"after_eur": 1063601.14,
"delta_eur": 372938.7,
"before_eur": 690662.44,
"amount_type": "kapitaal_toegestaan",
"effective_date": "2023-10-26",
"evidence_quote": "l\u0027assembl\u00E9e d\u00E9cide de renouveler l\u2019autorisation... d\u2019augmenter le capital \u00E0 concurrence d\u2019un maximum de 1.200.000 \u20AC",
"contribution_type": null
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}31-10-2023 Augmentation de capital de 372.938,70 € à 1.063.601,14 €
- €690.662,44 → €1.063.601,14
- Inbreng in natura · Apport en nature
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 1063601.14,
"delta_eur": 372938.69999999995,
"before_eur": 690662.44,
"contribution_type": "natura"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}03-01-2023 Augmentation de capital de 8.561.218,28 € à 9.251.880,72 €
- €690.662,44 → €9.251.880,72
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "agio_incorporation",
"after_eur": 9251880.72,
"delta_eur": 8561218.28,
"before_eur": 690662.44,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": "inschrijvingsrechten_uitgifte",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "convert_to_apports_non_appeles"
},
{
"kind": "capital_decrease",
"after_eur": 690662.44,
"delta_eur": -8561218.28,
"before_eur": 9251880.72,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": "loss_absorption",
"contribution_type": "kapitalisering_reserves",
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "suppress"
}
],
"notary": {
"name": "Benjamin Wets",
"firm_city": null,
"firm_name": "Benjamin Wets \u0026 Simon Wets, notaires associ\u00E9s",
"office_city": "Schaerbeek",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-01-03",
"filing_date": "2022-12-30",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-12-29",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"shareholders_after": [],
"share_classes_after": []
}03-01-2023 Augmentation de capital de 8.561.218,28 € à 9.251.880,72 €
- €690.662,44 → €9.251.880,72
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 9251880.72,
"delta_eur": 8561218.280000001,
"before_eur": 690662.44,
"contribution_type": "reserves_incorporation"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}03-01-2023 Augmentation de capital de 8.561.218,28 € à 9.251.880,72 €
- €690.662,44 → €9.251.880,72
- 2 kapitaalbewegingen in deze akte
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 9251880.72,
"delta_eur": 8561218.28,
"before_eur": 690662.44,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide donc d\u0027augmenter temporairement le capital \u00E0 concurrence de 8.561.218,28 \u20AC pour le porter de 690.662,44 \u20AC \u00E0 9.251.880,72 \u20AC.",
"contribution_type": "in_kind"
},
{
"kind": "capital_decrease",
"amount": 8561218.28,
"currency": "EUR",
"after_eur": 690662.44,
"delta_eur": -8561218.28,
"before_eur": 9251880.72,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-12-29",
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide de r\u00E9duire le capital \u00E0 concurrence de 8.561.218,28 \u20AC, sans annulation de titres, pour le ramener de 9.251.880,72 \u20AC \u00E0 690.662,44 \u20AC",
"contribution_type": "in_kind"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}22-12-2022 Marc DECHAMPS nommé administrateur
- Marc DECHAMPS — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0659744114",
"name": "SRL XMF",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-11-08",
"evidence_quote": "La SRL XMF, d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (immatricul\u00E9e \u00E0 la BCE sous le n\u00B00659.744.114 et dont le si\u00E8ge est situ\u00E9 Avenue Louis David 68 \u00E0 1410 Waterioo, Belgique), ayant pour repr\u00E9sentant permanent Monsieur Marc DECHAMPS, est nomm\u00E9e administrateur de Bioxodes"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}22-12-2022 3 administrateurs nommés
- Marc DECHAMPS — Bestuurder
- XMF — Gedelegeerd bestuurder
- AJE Consulting — Gedelegeerd bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": "0659.744.114",
"name": "SRL XMF",
"address": "Avenue Louis David 68, 1410 Waterloo",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "La SRL XMF, d\u00E9l\u00E9gu\u00E9e \u00E0 la gestion journali\u00E8re (immatricul\u00E9e \u00E0 la BCE sous le n\u00B00659.744.114 et dont le si\u00E8ge est situ\u00E9 Avenue Louis David 68 \u00E0 1410 Waterioo, Belgique), ayant pour repr\u00E9sentant permanent Monsieur Marc DECHAMPS, est nomm\u00E9e administrateur de Bioxodes",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "XMF",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "XMF en AJE Consulting zullen co-administrators d\u00E9l\u00E9gu\u00E9s zijn met concurrente beslissings- en vertegenwoordigingsbevoegdheden.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "delegation_dagelijks_bestuur_in",
"role": "gedelegeerd_bestuurder",
"person": null,
"reason": null,
"subkind": "additional",
"via_org": {
"kbo": null,
"name": "AJE Consulting",
"address": null,
"country": null,
"legal_form": null
},
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "XMF en AJE Consulting zullen co-administrators d\u00E9l\u00E9gu\u00E9s zijn met concurrente beslissings- en vertegenwoordigingsbevoegdheden.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2022-12-22",
"filing_date": "2022-12-12",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2022-11-08",
"unanimous": null
}
],
"is_correction": false,
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "avocate et mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}22-12-2022 2 administrateurs nommés
- XMF — Bestuurder
- Marc DECHAMPS — Représentant permanent
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "XMF",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent",
"person": {
"rrn": null,
"name": "Marc DECHAMPS",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}04-11-2022 Transfert du siège social de Marche-en-Famenne à Gosselies
- rue de la Plaine 11, 6900 Marche-en-Famenne → Santos Dumont 1, 6041 Gosselies
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Gosselies",
"region": "Waals",
"street": "Santos Dumont",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "1"
},
"old_address": {
"city": "Marche-en-Famenne",
"region": "Waals",
"street": "rue de la Plaine",
"country": "BE",
"postcode": "6900",
"box_number": null,
"street_number": "11"
},
"effective_date": "2022-10-14",
"evidence_quote": "Le si\u00E8ge social est transf\u00E9r\u00E9 rue Santos Dumont 1 \u00E0 6041 Gosselies avec effet imm\u00E9diat."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}04-11-2022 3 administrateurs nommés, 2 démissionnaires
- SRL XMF — Délégué à la gestion journalière et ceo
- AJE CONSULTING SRL — Chief operating officer et chief scientific officer
- rue Santos Dumont 1, 6041 Gosselies — Nouveau siège social
- siège social — Siège social
- rue de la Plaine 11, 6900 Marche-en-Famenne — Ancien siège social
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re et CEO",
"person": {
"rrn": null,
"name": "SRL XMF",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "Chief Operating Officer et Chief Scientific Officer",
"person": {
"rrn": null,
"name": "AJE CONSULTING SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "si\u00E8ge social",
"person": {
"rrn": null,
"name": "si\u00E8ge social",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "ancien si\u00E8ge social",
"person": {
"rrn": null,
"name": "rue de la Plaine 11, 6900 Marche-en-Famenne",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "nouveau si\u00E8ge social",
"person": {
"rrn": null,
"name": "rue Santos Dumont 1, 6041 Gosselies",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES"
}
}04-11-2022 2 reconduits
- Marc Dechamps — Dagelijks bestuur
- Edmond Godfroid — Dagelijks bestuur
Détails techniques
{
"events": [
{
"kind": "director_renew",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Marc Dechamps",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0659744114",
"name": "SRL XMF",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Confirmation de la nomination de la SRL XMF, ayant pour repr\u00E9sentant permanent Mr Marc Dechamps, comme d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re et CEO, \u00E0 dater du 5 octobre 2022 et pour une dur\u00E9e ind\u00E9termin\u00E9e."
},
{
"kind": "director_renew",
"role": "dagelijks_bestuur",
"person": {
"rrn": null,
"name": "Edmond Godfroid",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "AJE CONSULTING SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Confirmation de la nomination de AJE CONSULTING SRL, ayant pour repr\u00E9szentant permanent Edmond Godfroid, comme Chief Operating Officer et Chief Scientific Officer avec effet au 5 octobre 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
}
}04-11-2022 Transfert du siège social de Marche-en-Famenne à Gosselies
- Parc d'activités économiques du WEX, rue de la Plaine 11, 6900 Marche-en-Famenne → rue Santos Dumont 1 à 6041 Gosselies
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "rue Santos Dumont 1 \u00E0 6041 Gosselies",
"city": "Gosselies",
"region": "waals_gewest",
"street": "rue Santos Dumont",
"country": "BE",
"postcode": "6041",
"box_number": null,
"street_number": "1",
"locality_suffix": null
},
"old_address": {
"raw": "Parc d\u0027activit\u00E9s \u00E9conomiques du WEX, rue de la Plaine 11, 6900 Marche-en-Famenne",
"city": "Marche-en-Famenne",
"region": "waals_gewest",
"street": "rue de la Plaine",
"country": "BE",
"postcode": "6900",
"box_number": null,
"street_number": "11",
"locality_suffix": null
},
"effective_date": "2022-10-05",
"evidence_quote": "Le si\u00E8ge social est transf\u00E9r\u00E9 rue Santos Dumont 1 \u00E0 6041 Gosselies avec effet imm\u00E9diat.",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Francine MESSINNE",
"firm_city": null,
"firm_name": null,
"office_city": "Li\u00E8ge",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2022-11-04",
"filing_date": "2022-10-14",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2022-10-14",
"unanimous": true
},
"subject_company": {
"kbo": "0825.151.779",
"name_full": "BIOXODES",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Francine MESSINNE",
"org_rep_person_name": null,
"person_role_at_subject": "avocate et mandataire"
},
"co_filed_documents": [
"Acte notari\u00E9",
"D\u00E9p\u00F4t au greffe du Tribunal de l\u0027entreprise de Li\u00E8ge division Marche-en-Famenne"
]
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | BIOXODES |